NJ High Court Won't Disturb Novartis Bone Drug Win
The high court denied certification for the case, in which the state's appeals division had backed key lower-court rulings against plaintiff Jane Bessemer's direct-to-consumer advertising claims and failure-to-warn allegations. The certification order was filed Oct. 25 and publicly released earlier this month.
In June, a three-judge appeals panel...
To view the full article, register now.